Concepedia

Toniva Boone

TB

Statistics

Publications

4

Citations

188

H-Index

4

Active since

2018

Affiliations

Houston Methodist(Current)

Methodist Hospital

Weill Cornell Medicine

The University of Texas at San Antonio Health Science Center

Emory University

Toniva Boone is an author at Houston Methodist specializing in pharmacology, chemotherapy, and metastatic breast cancer treatment.

Publications per year

2018–2021

4

Publications

4

A randomized, controlled phase II trial of neoadjuvant ado-trastuzumab emtansine, lapatinib, and nab-paclitaxel versus trastuzumab, pertuzumab, and paclitaxel in HER2-positive breast cancer (TEAL study)

Tejal Patel, Sarah L. Creamer, Toniva Boone et al. · Breast Cancer Research · 2019 · 67 citations · Full text

, , +17

Targeting mTOR and DNA repair pathways in residual triple negative breast cancer post neoadjuvant chemotherapy

Kartik Anand, Tejal Patel, Polly Niravath et al. · Scientific Reports · 2021 · 55 citations · Full text

, , +17

A Phase II Study of the Efficacy and Safety of Chloroquine in Combination With Taxanes in the Treatment of Patients With Advanced or Metastatic Anthracycline-refractory Breast Cancer

Kartik Anand, Polly Niravath, Tejal Patel et al. · Clinical Breast Cancer · 2020 · 54 citations · Full text

, , +13

Phase ib study of trastuzumab emtansine (TDM1) in combination with lapatinib and nab-paclitaxel in metastatic HER2-neu overexpressed breast cancer patients: Stela results.

Tejal Patel, Joe Ensor, Angel Rodriguez et al. · Journal of Clinical Oncology · 2018 · 12 citations

, , +17

1–4 of 4